CRISPRベース遺伝子編集の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

CRISPRベース遺伝子編集市場の成長と動向：

Grand View Research, Incの調査レポートによると、世界のCRISPRベース遺伝子編集市場規模は2030年までに91億4,000万米ドルに達すると予測され、2024年から2030年までのCAGRは14.73％で成長すると予測されています。

この市場の力強い成長軌道は、遺伝性疾患の有病率の上昇、CRISPR技術の著しい進歩、支持的な規制の枠組み、バイオテクノロジーとヘルスケア研究への投資の増加など、いくつかの重要な要因によって推進されています。これらの要素が相まって、革新と発展のためのダイナミックな環境が生み出されています。

CRISPR技術の進歩は、顕著に市場拡大の原動力となっています。研究者は、CRISPR/Cas9、CRISPR/Cas12、新たな塩基編集技術など、より精密で効率的なCRISPRシステムの開発において目覚ましい進歩を遂げました。これらの技術革新は、潜在的な応用範囲を広げ、遺伝性疾患の治療から様々ながんや感染症に対する標的療法の策定にまで及んでいます。高い特異性と最小限のオフターゲット効果で遺伝子を編集する強化された能力は、製薬とバイオテクノロジーの両部門から大きな関心を集めており、これらの画期的な技術を治療開発に活用しようとする意欲が高まっています。

さらに、個別化医療が重視されるようになったことも、CRISPR技術の需要に大きな影響を与えています。ヘルスケアがより個別化された治療法へとシフトする中、遺伝子を正確に編集する能力によって、患者固有の遺伝子プロファイルに合わせた治療法の開発が可能になります。このような医療のパラダイムシフトは、CRISPR技術の採用をさらに加速させる可能性が高いです。CRISPR技術は、患者の転帰を劇的に改善できる、標的を絞った効果的な治療法を開発する比類のない機会を提供するからです。

支援的な規制の枠組みは、研究と商業化を促進する環境を育んでいます。規制機関はCRISPR技術の可能性をますます認識するようになっており、イノベーションを促進する合理的な承認プロセスにつながっています。全体として、これらの要因が重なり合うことで、市場は今後数年間、継続的な成長と革新が見込まれ、ヘルスケアとバイオテクノロジーにおける革命的な進歩への道が開かれます。

CRISPRベース遺伝子編集市場のレポートハイライト

• CRISPRキットおよび試薬、CRISPRライブラリ、その他の関連ツールを含む製品セグメントが、2023年に73.96%の最大収益シェアで市場をリードしました。
• 用途別では、バイオメディカル分野が2023年に81.83%の最大収益シェアで市場をリードし、予測期間中のCAGRも15.09%と最も早いと予測されています。この成長は、CRISPR技術の著しい進歩とともに、遺伝性疾患やがんの有病率の増加など、いくつかの主要な促進要因によって促進されています。
• 最終用途別では、製薬・バイオテクノロジー企業が2023年に46.31%の最大収益シェアで市場をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 CRISPRベース遺伝子編集市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場見通し。
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• CRISPRベース遺伝子編集市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 CRISPRベース遺伝子編集市場：製品とサービスの推定・動向分析

• セグメントダッシュボード
• 世界のCRISPRベース遺伝子編集市場の製品とサービスの変動分析
• 世界のCRISPRベース遺伝子編集市場規模と動向分析：製品とサービス別、2018年～2030年
• 製品
• サービス

第5章 CRISPRベース遺伝子編集市場：用途の推定・動向分析

• セグメントダッシュボード
• 世界のCRISPRベース遺伝子編集市場の用途変動分析
• CRISPRベース遺伝子編集の世界市場規模と動向分析：2018年から2030年までの用途別
• バイオメディカル
  • バイオメディカル市場推計・予測、2018年から2030年
  • 治療開発
  • 病気の診断
• 農業用途
  • 農業用途市場推計・予測、2018年から2030年
  • プラントエンジニアリング
  • 家畜工学
  • その他

第6章 CRISPRベース遺伝子編集市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界のCRISPRベース遺伝子編集市場の最終用途変動分析
• 世界のCRISPRベース遺伝子編集市場の規模と動向分析、最終用途別、2018年から2030年
• 製薬・バイオテクノロジー企業
• 学術研究機関
• 受託研究機関

第7章 CRISPRベース遺伝子編集市場：地域の推定・動向分析

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 北米市場推計・予測、2018年から2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州市場推計・予測、2018年から2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋市場推計・予測、2018年から2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ラテンアメリカ市場推計・予測、2018年から2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ市場推計・予測、2018年から2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• CRISPRベース遺伝子編集製品およびサービスの主要購入者リスト
• 企業プロファイル/リスト
  • Revvity, Inc.
  • Danaher Corporation
  • GenScript
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Tocris Bioscience
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne
  • New England Biolabs, Inc.

List of Tables

• Table 1. List of abbreviation
• Table 2. Global CRISPR-based gene editing market, by region, 2018 - 2030 (USD Million)
• Table 3. Global CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 4. Global CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 5. Global CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 6. North America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
• Table 7. North America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 8. North America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 9. North America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 10. U.S. CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 11. U.S. CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 12. U.S. CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 13. Canada CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 14. Canada CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 15. Canada CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 16. Mexico CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 17. Mexico CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 18. Mexico CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 19. Europe CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
• Table 20. Europe CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 21. Europe CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 22. Europe CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 23. UK CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 24. UK CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 25. UK CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 26. Germany CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 27. Germany CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 28. Germany CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 29. France CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 30. France CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 31. France CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 32. Italy CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 33. Italy CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 34. Italy CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 35. Spain CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 36. Spain CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 37. Spain CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 38. Denmark CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 39. Denmark CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 40. Denmark CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 41. Sweden CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 42. Sweden CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 43. Sweden CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 44. Norway CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 45. Norway CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 46. Norway CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 47. Asia Pacific CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 51. Japan CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 52. Japan CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 53. Japan CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 54. China CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 55. China CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 56. China CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 57. India CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 58. India CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 59. India CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 60. Australia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 61. Australia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 62. Australia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 63. South Korea CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 64. South Korea CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 65. South Korea CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 66. Thailand CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 67. Thailand CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 68. Thailand CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 69. Latin America CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
• Table 70. Latin America CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 71. Latin America CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 72. Latin America CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 73. Brazil CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 74. Brazil CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 75. Brazil CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 76. Argentina CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 77. Argentina CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 78. Argentina CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 79. MEA CRISPR-based gene editing market, by country, 2018 - 2030 (USD Million)
• Table 80. MEA CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 81. MEA CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 82. MEA CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 83. South Africa CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 84. South Africa CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 85. South Africa CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 86. Saudi Arabia CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 89. UAE CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 90. UAE CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 91. UAE CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)
• Table 92. Kuwait CRISPR-based gene editing market, by product & service, 2018 - 2030 (USD Million)
• Table 93. Kuwait CRISPR-based gene editing market, by application, 2018 - 2030 (USD Million)
• Table 94. Kuwait CRISPR-based gene editing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 CRISPR-based Gene Editing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 CRISPR-based Gene editing market: Product & service outlook key takeaways
• Fig. 20 CRISPR-based Gene editing market: Product & service movement analysis
• Fig. 21 Products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 CRISPR kits & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 CRISPR libraries market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Services market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 CRISPR-based gene editing market: Application outlook key takeaways
• Fig. 27 CRISPR-based gene editing market: Application movement analysis
• Fig. 28 Biomedical market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Therapeutic development market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Genetic disorders market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Ophthalmology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Ex vivo market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 In vivo market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Agricultural applications market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Plant engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Farm animals engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 CRISPR-based gene editing market: End use outlook key takeaways
• Fig. 42 CRISPR-based gene editing market: End use movement analysis
• Fig. 43 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Academic & research Institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Regional marketplace outlook, 2023 & 2030 (USD Million)
• Fig. 47 Regional marketplace: Key takeaways
• Fig. 48 North America CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 US CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 Canada CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Mexico CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Europe CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Key country dynamics
• Fig. 57 UK CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 Germany CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 France CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Key country dynamics
• Fig. 63 Spain CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Italy CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Key country dynamics
• Fig. 67 Denmark CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Key country dynamics
• Fig. 69 Sweden CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Key country dynamics
• Fig. 71 Norway CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Asia Pacific CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 Japan CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 China CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Key country dynamics
• Fig. 78 India CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Key country dynamics
• Fig. 80 Australia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Key country dynamics
• Fig. 82 South Korea CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Key country dynamics
• Fig. 84 Thailand CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Brazil CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Argentina CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 South Africa CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Key country dynamics
• Fig. 94 UAE CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 95 Key country dynamics
• Fig. 96 Kuwait CRISPR-based gene editing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 97 Market participant categorization
• Fig. 98 Company market position analysis, 2023
• Fig. 99 Strategic framework

CRISPR-based Gene Editing Market Growth & Trends:

The global CRISPR-based gene editing market size is anticipated to reach USD 9.14 billion by 2030 and is projected to grow at a CAGR of 14.73% from 2024 to 2030, according to a report by Grand View Research, Inc. This robust growth trajectory in the market is driven by several key factors, including the rising prevalence of genetic disorders, significant advancements in CRISPR technology, supportive regulatory frameworks, and increasing investments in biotechnology and healthcare research. Together, these elements create a dynamic environment for innovation and development.

Advancements in CRISPR technology have notably fueled market expansion. Researchers have made remarkable progress in developing more precise and efficient CRISPR systems, including CRISPR/Cas9, CRISPR/Cas12, and emerging base editing technologies. These innovations have broadened the scope of potential applications, extending from treating genetic disorders to formulating targeted therapies for various cancers and infectious diseases. The enhanced ability to edit genes with high specificity and minimal off-target effects has captured considerable interest from both pharmaceutical and biotechnology sectors, which are increasingly eager to leverage these groundbreaking technologies for therapeutic development.

Moreover, the growing emphasis on personalized medicine is significantly influencing the demand for CRISPR technologies. As the healthcare landscape shifts toward more individualized treatment approaches, the capability to edit genes with precision enables the creation of therapies tailored to the unique genetic profiles of patients. This paradigm shift in medicine is likely to further accelerate the adoption of CRISPR technologies, as they provide unparalleled opportunities to develop targeted and effective treatments that can dramatically improve patient outcomes.

Supportive regulatory frameworks are fostering a conducive environment for research and commercialization. Regulatory bodies are increasingly recognizing the potential of CRISPR technologies, leading to streamlined approval processes that encourage innovation. Overall, the confluence of these factors positions the market for continued growth and innovation in the coming years, paving the way for revolutionary advancements in healthcare and biotechnology.

CRISPR-based Gene Editing Market Report Highlights:

• The products segment, which includes CRISPR kits and reagents, CRISPR libraries, and other related tools, led the market with the largest revenue share of 73.96% in 2023
• Based on application, the biomedical segment led the market with the largest revenue share of 81.83% in 2023 and is also projected to witness at the fastest CAGR of 15.09% during the forecast period. This growth is fueled by several key drivers, including the increasing prevalence of genetic disorders and cancers, alongside significant advancements in CRISPR technology
• Based on end use, the pharmaceutical & biotechnology companies segment led the market with the largest revenue share of 46.31% in 2023

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Application Segment
  • 1.2.3. End-use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of genetic disorders
    • 3.2.1.2. Growing investments in biotechnology and healthcare research
    • 3.2.1.3. Advancements in CRISPR technology and applications
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical concerns surrounding gene editing
    • 3.2.2.2. High costs associated with CRISPR research and development
• 3.3. CRISPR-based Gene Editing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
• 4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. CRISPR Kits & Reagents
    • 4.4.2.1. CRISPR kits & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. CRISPR Libraries
    • 4.4.3.1. CRISPR libraries market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
• 5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Biomedical
  • 5.4.1. Biomedical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4.2. Therapeutic Development
    • 5.4.2.1. Therapeutic development market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2.2. By Indication
      • 5.4.2.2.1. Genetic Disorders
        • 5.4.2.2.1.1. Genetic Disorders market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2.2. Oncology
        • 5.4.2.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2.3. Ophthalmology
        • 5.4.2.2.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.2.2.4. Others
        • 5.4.2.2.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2.3. By Delivery Method
      • 5.4.2.3.1. Ex Vivo
      • 5.4.2.3.2. Ex vivo market estimates and forecasts, 2018 to 2030 (USD Million
      • 5.4.2.3.3. In Vivo
      • 5.4.2.3.4. In vivo market estimates and forecasts, 2018 to 2030 (USD Million
  • 5.4.3. Disease Diagnostics
    • 5.4.3.1. Disease diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Agricultural applications
  • 5.5.1. Agricultural applications market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5.2. Plant Engineering
    • 5.5.2.1. Plant engineering market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5.3. Farm Animals Engineering
    • 5.5.3.1. Farm animals engineering market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. CRISPR-based Gene Editing Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global CRISPR-based Gene Editing Market End-use Movement Analysis
• 6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Academic & Research Institutes
  • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Contract Research Organizations
  • 6.6.1. Contract research organizations market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Target disease prevalence
    • 7.4.2.4. Regulatory framework
    • 7.4.2.5. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Target disease prevalence
    • 7.4.3.4. Regulatory framework
    • 7.4.3.5. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Target disease prevalence
    • 7.4.4.4. Regulatory framework
    • 7.4.4.5. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Target disease prevalence
    • 7.5.2.4. Regulatory framework
    • 7.5.2.5. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Target disease prevalence
    • 7.5.3.4. Regulatory framework
    • 7.5.3.5. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Target disease prevalence
    • 7.5.4.4. Regulatory framework
    • 7.5.4.5. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Target disease prevalence
    • 7.5.5.4. Regulatory framework
    • 7.5.5.5. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Target disease prevalence
    • 7.5.6.4. Regulatory framework
    • 7.5.6.5. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Target disease prevalence
    • 7.5.7.4. Regulatory framework
    • 7.5.7.5. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Competitive scenario
    • 7.5.8.3. Target disease prevalence
    • 7.5.8.4. Regulatory framework
    • 7.5.8.5. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamics
    • 7.5.9.2. Competitive scenario
    • 7.5.9.3. Target disease prevalence
    • 7.5.9.4. Regulatory framework
    • 7.5.9.5. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Target disease prevalence
    • 7.6.2.4. Regulatory framework
    • 7.6.2.5. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Target disease prevalence
    • 7.6.3.4. Regulatory framework
    • 7.6.3.5. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Target disease prevalence
    • 7.6.4.4. Regulatory framework
    • 7.6.4.5. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Target disease prevalence
    • 7.6.5.4. Regulatory framework
    • 7.6.5.5. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Target disease prevalence
    • 7.6.6.4. Regulatory framework
    • 7.6.6.5. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Target disease prevalence
    • 7.6.7.4. Regulatory framework
    • 7.6.7.5. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Target disease prevalence
    • 7.7.2.4. Regulatory framework
    • 7.7.2.5. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Target disease prevalence
    • 7.7.3.4. Regulatory framework
    • 7.7.3.5. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Target disease prevalence
    • 7.8.2.4. Regulatory framework
    • 7.8.2.5. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive scenario
    • 7.8.3.3. Target disease prevalence
    • 7.8.3.4. Regulatory framework
    • 7.8.3.5. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive scenario
    • 7.8.4.3. Target disease prevalence
    • 7.8.4.4. Regulatory framework
    • 7.8.4.5. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive scenario
    • 7.8.5.3. Target disease prevalence
    • 7.8.5.4. Regulatory framework
    • 7.8.5.5. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2023
• 8.4. List of Key Buyers for CRISPR-based Gene Editing Products & Services
• 8.5. Company Profiles/Listing
  • 8.5.1. Revvity, Inc.
    • 8.5.1.1. Company overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product/Service benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Danaher Corporation
    • 8.5.2.1. Company overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product/Service benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. GenScript
    • 8.5.3.1. Company overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product/Service benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Merck KGaA
    • 8.5.4.1. Company overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product/Service benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. Thermo Fisher Scientific, Inc.
    • 8.5.5.1. Company overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product/Service benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Tocris Bioscience
    • 8.5.6.1. Company overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product/Service benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. OriGene Technologies, Inc.
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product/Service benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Bio-Rad Laboratories
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product/Service benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Bio-Techne
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product/Service benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. New England Biolabs, Inc.
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product/Service benchmarking
    • 8.5.10.4. Strategic initiatives